The Biotechnology Industry Organization announced a name change to the Biotechnology Innovation Organization, effective in early 2016.

Catalent’s Singapore facility is awarded GMP certification.

Vetter completes on-site expansion activities of visual inspection and in-process control at Chicago facility.

Bayer Healthcare, Bristol-Myers Squibb, Sucampo Pharmaceuticals, Takeda Pharmaceuticals, and Horizon Pharma representatives join PhRMA board.

West Pharmaceutical began construction on its component manufacturing facility located in Waterford, Ireland.

At BIO 2015, CQDM and MaRS Innovation announced an investment in Encycle Therapeutics to research chemical properties needed to make peptide-like molecules orally bioavailable.

The agency creates initiative to stimulate pediatric drug development.

CPhI Worldwide announces five new categories for the 2015 CPhI Pharma Awards.

BPTF seeks changes in performance goals and fee payment schedule in GDUFA renegotiations.

With drug development trends shifting towards personalized medicines, new technologies are needed for the manufacture of these highly sensitive drug products.

An advisory panel deemed Amgen’s Repatha (evolocumab) to be safe overall.

The exclusive manufacturing collaboration will establish production for adeno-associated virus gene-therapy treatments incorporating REGENXBIO’s NAV Technology.

An FDA advisory panel voted 13-3 in favor of approval of Sanofi and Regeneron Pharmaceuticals' cholesterol-homeostasis therapy Praluent (alirocumab).

The supplier will add Allied Laboratories and AR Brown to its list of global partners.

The product, marketed as Sirdupla in the United Kingdom, is the generic version of GSK’s beta agonist and corticosteroid combination treatment for asthma.

The agency issues draft guidance on the development of drugs to treat Duchenne muscular dystrophy.

A year after its merger with DSM Pharmaceutical Products, Patheon announces that it has filed an IPO.

As FDA advisory committees meet on two potential PCSK9 inhibitors, Prime Therapeutics analyzes the impact that this class of drugs may have on overall drug spending.

Lyophilization Services of New England announces inspection approvals that will allow its Bedford, NH facility to begin manufacturing commercial drugs for US distribution.

The MF80 automated punch polisher offers increased polishing capacity per cycle.

At this year’s ACHEMA, Malvern brings to the exhibition floor, its expertise and tools for measuring particle size and shape, zeta potential, molecular weight, and rheological properties for the characterization of dispersed systems.

The design of the shovel means that less drive power is required compared with a standard shovel, thus resulting in substantial energy savings.

Talks will explore key trends and issues in the pharmaceutical space and address the “latest industry buzz.”

Pioneering system provides induction sealing integrity analysis for 100% of bottles without packaging line slowdown.

Bosch’s market launches at the show include a new bioreactor for laboratory-scale API development, a water-for-injection unit, and a new generation of pure steam generators with high yields.

Products on display include the newest addition to the Mobius line of single-use bioreactors; Cellvento CHO cell culture media for optimized production of specific cell lines; and new high-volume AFS water purification systems.

Porvair has developed a 2-ml 96 round-well deep-well plate that enables scientists to use the full 2.00 ml well capacity.

PSL has developed a dispensary isolator with a contained drum hoist mechanism for highly potent API production.